← Open Payments lookup

FRANCISCO RUGAMA: Open Payments

NPI 1780205526 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,223 in 70 payments from 21 companies in 2025. Trend: 2023 $410 · 2024 $1,292 · 2025 $1,223

Food & beverage: $1,223
CompanyPaymentsAmount
Novo Nordisk Inc15$214
ABBVIE INC.12$142
Otsuka America Pharmaceutical, Inc.7$136
PFIZER INC.5$101
Merck Sharp & Dohme LLC4$88
Lilly USA, LLC3$70
GlaxoSmithKline, LLC.4$69
Verona Pharma, Inc.2$50
AstraZeneca Pharmaceuticals LP2$48
Dexcom, Inc.2$42

Products named: REXULTI, Ozempic, ELIQUIS, VERQUVO, TRELEGY ELLIPTA, UBRELVY, Wegovy, JARDIANCE.

Industry payments across TX — which companies pay providers there.